Literature DB >> 23995235

Epigenetic and transcriptional signatures of stable versus plastic differentiation of proinflammatory γδ T cell subsets.

Nina Schmolka1, Karine Serre1, Ana R Grosso1, Margarida Rei1,2, Daniel J Pennington2, Anita Q Gomes1,3, Bruno Silva-Santos1,4.   

Abstract

Two distinct subsets of γδ T cells that produce interleukin 17 (IL-17) (CD27(-) γδ T cells) or interferon-γ (IFN-γ) (CD27(+) γδ T cells) develop in the mouse thymus, but the molecular determinants of their functional potential in the periphery remain unknown. Here we conducted a genome-wide characterization of the methylation patterns of histone H3, along with analysis of mRNA encoding transcription factors, to identify the regulatory networks of peripheral IFN-γ-producing or IL-17-producing γδ T cell subsets in vivo. We found that CD27(+) γδ T cells were committed to the expression of Ifng but not Il17, whereas CD27(-) γδ T cells displayed permissive chromatin configurations at loci encoding both cytokines and their regulatory transcription factors and differentiated into cells that produced both IL-17 and IFN-γ in a tumor microenvironment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23995235      PMCID: PMC4834994          DOI: 10.1038/ni.2702

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  59 in total

1.  Chemokine receptor CCR1 regulates inflammatory cell infiltration after renal ischemia-reperfusion injury.

Authors:  Kengo Furuichi; Ji-Liang Gao; Richard Horuk; Takashi Wada; Shuichi Kaneko; Philip M Murphy
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

2.  Skint-1 identifies a common molecular mechanism for the development of interferon-γ-secreting versus interleukin-17-secreting γδ T cells.

Authors:  Gleb Turchinovich; Adrian C Hayday
Journal:  Immunity       Date:  2011-07-07       Impact factor: 31.745

Review 3.  Targeting γδ T lymphocytes for cancer immunotherapy: from novel mechanistic insight to clinical application.

Authors:  Anita Q Gomes; Duarte S Martins; Bruno Silva-Santos
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

4.  Cutting edge: Vascular endothelial growth factor-mediated signaling in human CD45RO+ CD4+ T cells promotes Akt and ERK activation and costimulates IFN-gamma production.

Authors:  Aninda Basu; Andre Hoerning; Dipak Datta; Monika Edelbauer; Maria P Stack; Katiana Calzadilla; Soumitro Pal; David M Briscoe
Journal:  J Immunol       Date:  2009-12-11       Impact factor: 5.422

5.  Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals.

Authors:  Bruno Martin; Keiji Hirota; Daniel J Cua; Brigitta Stockinger; Marc Veldhoen
Journal:  Immunity       Date:  2009-08-13       Impact factor: 31.745

6.  The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans.

Authors:  Kellie A Charles; Hagen Kulbe; Robin Soper; Monica Escorcio-Correia; Toby Lawrence; Anne Schultheis; Probir Chakravarty; Richard G Thompson; George Kollias; John F Smyth; Frances R Balkwill; Thorsten Hagemann
Journal:  J Clin Invest       Date:  2009-09-08       Impact factor: 14.808

7.  Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development.

Authors:  Klaus Griewank; Christine Borowski; Svend Rietdijk; Ninghai Wang; Aimee Julien; Datsen G Wei; Alusha A Mamchak; Cox Terhorst; Albert Bendelac
Journal:  Immunity       Date:  2007-11       Impact factor: 31.745

8.  EphrinB1-EphB signaling regulates thymocyte-epithelium interactions involved in functional T cell development.

Authors:  David Alfaro; José J García-Ceca; Teresa Cejalvo; Eva Jiménez; Eric J Jenkinson; Graham Anderson; Juan J Muñoz; Agustín Zapata
Journal:  Eur J Immunol       Date:  2007-09       Impact factor: 5.532

9.  DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation.

Authors:  Haifa H Jabara; Douglas R McDonald; Erin Janssen; Michel J Massaad; Narayanaswamy Ramesh; Arturo Borzutzky; Ingrid Rauter; Halli Benson; Lynda Schneider; Sachin Baxi; Mike Recher; Luigi D Notarangelo; Rima Wakim; Ghassan Dbaibo; Majed Dasouki; Waleed Al-Herz; Isil Barlan; Safa Baris; Necil Kutukculer; Hans D Ochs; Alessandro Plebani; Maria Kanariou; Gerard Lefranc; Ismail Reisli; Katherine A Fitzgerald; Douglas Golenbock; John Manis; Sevgi Keles; Reuben Ceja; Talal A Chatila; Raif S Geha
Journal:  Nat Immunol       Date:  2012-05-13       Impact factor: 25.606

10.  Model-based analysis of ChIP-Seq (MACS).

Authors:  Yong Zhang; Tao Liu; Clifford A Meyer; Jérôme Eeckhoute; David S Johnson; Bradley E Bernstein; Chad Nusbaum; Richard M Myers; Myles Brown; Wei Li; X Shirley Liu
Journal:  Genome Biol       Date:  2008-09-17       Impact factor: 13.583

View more
  42 in total

1.  γδ T cells and epigenetic drugs: A useful merger in cancer immunotherapy?

Authors:  Jaydeep Bhat; Dieter Kabelitz
Journal:  Oncoimmunology       Date:  2015-04-28       Impact factor: 8.110

Review 2.  Epigenetic reprogramming of immune cells in injury, repair, and resolution.

Authors:  Katarzyna Placek; Joachim L Schultze; Anna C Aschenbrenner
Journal:  J Clin Invest       Date:  2019-07-22       Impact factor: 14.808

3.  Critical Role for SLAM/SAP Signaling in the Thymic Developmental Programming of IL-17- and IFN-γ-Producing γδ T Cells.

Authors:  Oliver Dienz; Victoria L DeVault; Shawn C Musial; Somen K Mistri; Linda Mei; Aleksandr Baraev; Julie A Dragon; Dimitry Krementsov; Andre Veillette; Jonathan E Boyson
Journal:  J Immunol       Date:  2020-02-05       Impact factor: 5.422

Review 4.  Immunity and immune modulation in Trypanosoma cruzi infection.

Authors:  Fabíola Cardillo; Rosa Teixeira de Pinho; Paulo Renato Zuquim Antas; José Mengel
Journal:  Pathog Dis       Date:  2015-10-04       Impact factor: 3.166

Review 5.  γδ T Cells: Unexpected Regulators of Cancer Development and Progression.

Authors:  Christopher Fleming; Samantha Morrissey; Yihua Cai; Jun Yan
Journal:  Trends Cancer       Date:  2017-07-17

6.  γδ T cells restrain extrathymic development of Foxp3+-inducible regulatory T cells via IFN-γ.

Authors:  Anabelle Visperas; Bo Shen; Booki Min
Journal:  Eur J Immunol       Date:  2014-05-30       Impact factor: 5.532

7.  Potentially pathogenic immune cells and networks in apparently healthy lacrimal glands.

Authors:  Austin K Mircheff; Yanru Wang; Chuanqing Ding; Dwight W Warren; Joel E Schechter
Journal:  Ocul Surf       Date:  2014-11-06       Impact factor: 5.033

Review 8.  IL-17+ γδ T cells as kick-starters of inflammation.

Authors:  Pedro H Papotto; Julie C Ribot; Bruno Silva-Santos
Journal:  Nat Immunol       Date:  2017-05-18       Impact factor: 25.606

9.  MicroRNA-146a controls functional plasticity in γδ T cells by targeting NOD1.

Authors:  Nina Schmolka; Pedro H Papotto; Paula Vargas Romero; Tiago Amado; Francisco J Enguita; Ana Amorim; Ana F Rodrigues; Katrina E Gordon; Ana S Coroadinha; Mark Boldin; Karine Serre; Amy H Buck; Anita Q Gomes; Bruno Silva-Santos
Journal:  Sci Immunol       Date:  2018-05-04

Review 10.  γδ T cells in cancer.

Authors:  Bruno Silva-Santos; Karine Serre; Håkan Norell
Journal:  Nat Rev Immunol       Date:  2015-10-09       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.